Global Huber Needles Market Trends, Forecast Report 2025-2037
Huber Needles Market size is set to increase from USD 51.44 million to USD 163.07 million, witnessing a CAGR of around 9.2% during the forecast period, from 2025 through 2037. In the year 2025, the industry size of huber needles is estimated at USD 55.27 million.
The market growth is attributed to worldwide increasing prevalence of chronic renal diseases. For instance, chronic kidney disease is a degenerative disorder that affects more than 12% of the global population, that represents more than 900 million people.
Huber needles are hollow needles that have slant tip to make it easy to go throw skin. These needles are primarily used for recurrent access to veins for blood extraction and the infusion of blood products, medicine, and nutritional solutions in combination with a point implanted in the body of a persistently ill patient. Increasing use of huber needles for the treatment of hepatitis and HIV is fueling the huber needles market growth. As per the statistics provided by the World Health Organization (WHO), more than 350 million people worldwide are still surviving with the risk of hepatitis B or C infection.
Huber Needles Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Prevalence of Needle Stick Injuries in Healthcare Workers – Needle stick injuries are injuries caused by needles that pierce the skin by accident. Needle stick injuries are a risk for everyone who works with intravenous syringes or other needle-related equipment. These injuries most commonly occur when persons, such as nursing students, use, dismantle, or discard of needles. Therefore, surging cases of needle stick injuries in healthcare workers are lifting up the huber needles market growth. For instance, presently, in the United States alone, over 5 million healthcare professionals are at risk of exposure to blood borne infections caused by needle stick or other sharp objects injuries.
- Global Surge in HIV Prevalence – According to the World Health Organization data, an anticipated 1.5 million (UI 1.0 to 2.0 million) people were infected with HIV for the first time. This carried the worldwide HIV population to 38.4 million people by 2021.
- Worldwide Growing Occurrence of Cancer - According to World Health Organization (WHO) figures, approximately 10 million people died from cancer worldwide in 2020.
- Increasing Ratio of Obesity in People Across the Globe – For instance, more than 2 billion people globally, including 700 million adults, 380 million teenagers, and 45 million children, are affected by obesity.
- Worldwide Spike in Healthcare Expenditure - According to the World Bank statistics, worldwide healthcare expenditure accelerated by 9.83% in 2019.
Challenges
- High Cost Associated with The Manufacturing of Huber Needle Product
- Lack of Technological Advancement
- High Risk of Contamination
Global Huber Needles Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.2% |
|
Base Year Market Size (2024) |
USD 51.44 million |
|
Forecast Year Market Size (2037) |
USD 163.07 million |
|
Regional Scope |
|
Huber Needles Segmentation
Application (Dialysis, Blood Transfusion, Application for Cancer, Lap-band Adjustments, Home Parenteral Nutrition)
The blood transfusion segment is poised to dominate largest huber needles market share by the end of 2037, on the back of the staggering increase in blood transfusion throughout the world. Based on the data released by the World Health Organization, worldwide, nearly 118.54 million blood transfusions are collected.
Our in-depth analysis of the global huber needles market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportHuber Needles Industry - Regional Synopsis
North America is projected to hold largest huber needles market share by the end of 2037, backed by significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders. For instance, approximately 790,000 individuals in the United States developed ESKD, also widely recognized as an end-stage renal disease (ESRD), in 2020, with 75% were receiving dialysis and 30% receiving a kidney transplant.
Companies Dominating the Huber Needles Market
- B. Braun Medical Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ICU Medical, Inc.
- Baxter International, Inc.
- Nipro Medical Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Vygon SAS
- EXELINT International, Co.
- Medtronic
- Terumo Corporation
In the News
-
Becton, Dickinson and Company introduced a new generation of prefillable syringes (PFS) that sets a new benchmark for vaccine PFS performance. In collaboration with leading pharmaceutical companies, the new BD Effivax Glass Prefillable Syringe has been designed to meet the complex and evolving needs of vaccine manufacturers.
-
CU Medical, Inc., has acquired the Smiths Medical from Smiths Group plc., who is a leading provider of syringe and ambulatory infusion devices, vascular access, and vital care products.
Author Credits: Radhika Pawar
- Report ID: 319
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
